secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2024-09-20T23:59:59+00:00
Accession:  0001493152-24-037254
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics prices $4.3M registered direct offering of 1,363,812 shares at $3.15/share
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.3M before fees; closing expected Sept 20, 2024.
- Placement agent H.C. Wainwright receives 7% cash fee plus 95,467 warrants at $3.9375.
- Net proceeds to be used for working capital and general corporate purposes.
- No warrants issued to investors; offering priced at-the-market under Nasdaq rules.
- Shares sold under effective shelf registration statement (File No. 333-262554).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224037254/0001493152-24-037254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315224037254/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-037254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer